Mrv0541 02231220182D 18 17 0 0 1 0 999 V2000 14.7017 -4.1621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 17.5595 -4.9872 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 15.4161 -2.9246 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 20.4174 -4.1621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 19.7029 -2.9246 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 16.8451 -3.7496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 14.7017 -7.4621 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 18.9885 -4.9872 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 16.1307 -4.9872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.1307 -4.1621 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 15.4161 -5.3997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.4161 -6.2246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.7017 -6.6371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.2741 -3.7496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.5595 -4.1621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.4161 -3.7496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.9885 -4.1621 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 19.7029 -3.7496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 16 1 0 0 0 0 2 15 2 0 0 0 0 3 16 2 0 0 0 0 4 18 1 0 0 0 0 5 18 2 0 0 0 0 10 6 1 1 0 0 0 6 15 1 0 0 0 0 7 13 1 0 0 0 0 17 8 1 1 0 0 0 9 10 1 0 0 0 0 9 11 1 0 0 0 0 10 16 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 14 15 1 0 0 0 0 14 17 1 0 0 0 0 17 18 1 0 0 0 0 M END > BMDB0004985 > bmdb > NCCCC[C@H](NC(=O)C[C@H](N)C(O)=O)C(O)=O > InChI=1S/C10H19N3O5/c11-4-2-1-3-7(10(17)18)13-8(14)5-6(12)9(15)16/h6-7H,1-5,11-12H2,(H,13,14)(H,15,16)(H,17,18)/t6-,7-/m0/s1 > QGNYWQOMJSTUQZ-BQBZGAKWSA-N > C10H19N3O5 > 261.275 > 261.132470733 > 7 > 26.215854819202896 > 1 > 5 > 0 > 0 > (2S)-6-amino-2-[(3S)-3-amino-3-carboxypropanamido]hexanoic acid > -4.07 > -6.4133430177957855 > -1.63 > 0 > 0 > 0 > 3.684373669006159 > 1.8801141258081282 > 10.212679648406661 > 155.74 > 61.14230000000002 > 9 > 1 > 6.12e+00 g/l > (2S)-6-amino-2-[(3S)-3-amino-3-carboxypropanamido]hexanoic acid > 0 > BMDB0004985 > Aspartylysine > Asp-LYS; Aspartyllysine; Beta-aspartyl-epsilon-lysine; e-(b-Aspartyl)lysine; e-(b-L-Aspartyl)-L-lysine; epsilon-(b-Aspartyl)lysine; epsilon-(b-L-Aspartyl)-L-lysine; N-epsilon-(beta-aspartyl)lysine; N6-L-beta-aspartyl-L-Lysine; Ne-(b-Aspartyl)-L-lysine $$$$